Site Under Development, Content Population and SEO, Soft Launch 1st January 2020

Medical News (World)
Keeping you updated with medical happennings in specific countries or global medical trends or issues.
Presented by
Staff Writer, TMN  Jul 01, 2018
Amgen announced that the results of two open-label extension (OLE) studies of AimovigTM (erenumab-aooe) in patients with chronic and episodic migraine, respectively, will be presented at the 60th Annual Scientific Meeting of the American Headache Society (AHS) in San Francisco. Results from a one-year study in chronic migraine patients reinforced the established safety and efficacy profile of Aimo...